1. New method to differentiate between lupus anticoagulants, progressive coagulation inhibitors and coagulation factor deficiencies in the mixing tests.
- Author
-
Shimomura, Daiki, Kumano, Osamu, Ueda, Kaori, Kitano, Keisuke, Arai, Nobuo, Shimada, Masashi, and Kamioka, Mikio
- Subjects
ANTICOAGULANTS ,CHEMICAL reagents ,DESCRIPTIVE statistics ,BLOOD coagulation factors ,PARTIAL thromboplastin time ,IMMUNOMODULATORS ,SENSITIVITY & specificity (Statistics) ,ANTIPHOSPHOLIPID syndrome - Abstract
Introduction: Mixing tests in activated partial thromboplastin time (APTT) are used for the differentiation between lupus anticoagulants (LA), coagulation inhibitors, and factor deficient samples with APTT prolongation. However, the indexes for the differentiation have not been established. The present study aimed to develop new mixing test indexes for the differentiation. Methods: Twenty‐six LA‐positive, 8 progressive coagulation factor VIII inhibitor, and 35 coagulation deficient samples were employed. APTT were measured for normal plasma, patient plasma, and mixing plasma prepared at a ratio of 1:1 proportion in both without incubation and 2 h‐incubation. New two parameters named as ALD50 and mixture plasma—patient plasma after Warming change rate Subtraction (WaS) calculated from the clotting times of normal, 1:1 mixing and patient samples with/without 2 h‐incubation were established. In the samples with WaS result of <10.2%, ALD50 of ≥87.8%, and < 87.8% were defined as LA and coagulation factor deficiency, respectively, and WaS of ≥10.2% defined progressive coagulation factor inhibitors. Results: Sensitivity and specificity to LA were 80.8% and 93.0% for ALD50, and sensitivity and specificity to progressive coagulation factor inhibitor were 100.0% and 100.0% for WaS, respectively. The agreement between sample classification and WaS‐ALD50 was 88.4% (61/69). Conclusions: ALD50 and WaS showed acceptable sensitivity and specificity to LA and progressive coagulation factor inhibitor, respectively. These indexes would be useful for the differentiation between LA, factor deficiency, and progressive coagulation factor inhibitor in the mixing tests. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF